Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.7001
+0.0096 (1.39%)
At close: Aug 29, 2025, 4:00 PM
0.6868
-0.0133 (-1.90%)
After-hours: Aug 29, 2025, 6:27 PM EDT

Xilio Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts that cover Xilio Therapeutics stock have a consensus rating of "Buy" and an average price target of $3.00, which forecasts a 328.51% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $4.00.

Price Target: $3.00 (+328.51%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$2.00$3.00$4.00$4.00
Change+185.67%+328.51%+471.35%+471.35%

Analyst Ratings

The average analyst rating for Xilio Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy000000
Buy111112
Hold000000
Sell000000
Strong Sell000000
Total111112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Leerink Partners
Leerink Partners
Buy
Initiates
$2
BuyInitiates$2+185.67%Aug 6, 2025
Raymond James
Raymond James
Buy
Maintains
$6$4
BuyMaintains$6$4+471.35%Nov 8, 2024
Chardan Capital
Chardan Capital
Strong Buy
Reiterates
$7
Strong BuyReiterates$7+899.86%May 30, 2023
Chardan Capital
Chardan Capital
Strong Buy
Reiterates
$7
Strong BuyReiterates$7+899.86%May 11, 2023
Morgan Stanley
Morgan Stanley
Buy
Maintains
$20$10
BuyMaintains$20$10+1,328.37%Jan 27, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
68.65M
from 6.34M
Increased by 982.12%
Revenue Next Year
26.47M
from 68.65M
Decreased by -61.45%
EPS This Year
-0.16
from -1.09
EPS Next Year
-0.37
from -0.16
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
----6.34M68.65M26.47M
Revenue Growth
-----982.12%-61.45%
EPS
-105.42-13.52-3.22-2.78-1.09-0.16-0.37
EPS Growth
-------
Forward PE
-------
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High108.9M32.3M
Avg68.7M26.5M
Low31.6M21.2M

Revenue Growth

Revenue Growth20252026202720282029
High
1,617.1%
-52.9%
Avg
982.1%
-61.4%
Low
397.4%
-69.2%

EPS Forecast

EPS202520262027
High0.16-0.29
Avg-0.16-0.37
Low-0.45-0.44

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.